Multicenter phase I trial of sorafenib (S) in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation (LT).
Abby B. Siegel
Research Funding - Bayer/Onyx
Anthony B. El-Khoueiry
Consultant or Advisory Role - Bayer/Onyx
Research Funding - Bayer/Onyx
Richard S. Finn
Consultant or Advisory Role - Bayer/Onyx
Abhishek Goyal
No relevant relationships to disclose
Charles David Blanke
No relevant relationships to disclose
Robert S. Brown
No relevant relationships to disclose